
Axcella Health AXLA
Quarterly report 2023-Q2
added 05-16-2026
Axcella Health ROE Ratio 2011-2026 | AXLA
Annual ROE Ratio Axcella Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1949.71 | -293.66 | -74.99 | -98.03 | 24.09 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.09 | -1949.71 | -478.46 |
Quarterly ROE Ratio Axcella Health
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -388.66 | -603.5 | -56.6 | -100.5 | -369.88 | -165.37 | -101.68 | -115.69 | -86.73 | -85.65 | -61.02 | -84.29 | -86.34 | -64.18 | -32.11 | -26.25 | 3.32 | 24.79 | 17.57 | 5.87 | 6.29 | 5.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 24.79 | -603.5 | -107.51 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-528.29 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-32.54 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.7 | 3.03 % | $ 452 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
-5.91 | $ 92.14 | 1.33 % | $ 22.3 B | ||
|
AstraZeneca PLC
AZN
|
21.0 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
30.52 | - | 0.74 % | $ 768 M | ||
|
Compugen Ltd.
CGEN
|
34.4 | $ 2.8 | 7.28 % | $ 262 M | ||
|
Abcam plc
ABCM
|
-1.17 | - | - | $ 4.9 B | ||
|
Galera Therapeutics
GRTX
|
3750.6 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-55.98 | - | -18.52 % | $ 27.3 M | ||
|
Affimed N.V.
AFMD
|
-183.26 | - | -34.95 % | $ 21.5 M | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-948.23 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-69.02 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
-152.74 | - | - | $ 344 M | ||
|
IMV
IMV
|
575.45 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
43.82 | - | -4.36 % | $ 27 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-169.75 | - | - | $ 384 M | ||
|
Gracell Biotechnologies
GRCL
|
-44.16 | - | - | $ 3.37 B | ||
|
Coherus BioSciences
CHRS
|
275.39 | $ 1.61 | 2.55 % | $ 189 M | ||
|
Anika Therapeutics
ANIK
|
-7.58 | $ 14.88 | -0.93 % | $ 213 M | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.4 | -1.16 % | $ 5.6 M | ||
|
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
-146.95 | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 20.86 | -0.71 % | $ 2.65 B | ||
|
Allena Pharmaceuticals
ALNA
|
-54.92 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B |